John B Moriarty

CIK 1564621 · Chief Legal Officer · last filed 2026-06-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$1.13M
Companies
6
Total Filings
58
Lifetime Open-Market Net
-$252.8K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

RNA price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
C/O AVIDITY BIOSCIENCES, INC.
10578 SCIENCE CENTER DRIVE, SUITE 125
SAN DIEGO, CA 92121
Related Filers
ALEXION PHARMACEUTICALS, INC. — 27 joint filings, latest 2018-02-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KARD Chief Legal Officer 47,784 $12.74 $608.8K $0 1 2026-06-22
Avidity Biosciences, Inc. (RNAM) Delisted Chief Legal Officer 0 — — $0 1 2026-02-27
RNA Chief Legal Officer 74,557 $6.97 $520.0K -$252.8K 5 2026-01-09
Mirati Therapeutics, Inc. (MRTX) Delisted Chief Legal Officer 0 $58.70 $0 $0 2 2024-01-23
OLMA EVP, Ch. Legal Officer & Sec. — $7.11 — $0 3 2023-02-02
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted EVP, General Counsel 0 — — $0 7 2020-07-02

Recent Filings · Page 2 of 6

58 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2023-07-18 OLMA Notice (144)
Former Officer · Planned Jul 18, 2023
Sold: listed on the Jul 20, 2023 notice
−15,000 -$133.8K EDGAR
2023-06-29 OLMA Notice (144)
Former Officer · Planned Jun 29, 2023
Sold: listed on the Jul 18, 2023 notice
−7,500 -$71.2K EDGAR
2023-06-28 OLMA Notice (144)
Former Officer · Planned Jun 28, 2023
Sold: listed on the Jun 29, 2023 notice
−12,851 -$123.1K EDGAR
2023-06-27 OLMA Notice (144)
Former Officer · Planned Jun 27, 2023
Sold: listed on the Jun 28, 2023 notice
−15,029 -$133.3K EDGAR
2023-06-15 OLMA Notice (144)
Officer, Former Officer · Planned Jun 15, 2023
Sold: listed on the Jun 27, 2023 notice
−31 -$287 EDGAR
2023-06-14 OLMA Notice (144)
Officer · Planned Jun 14, 2023
Sold: listed on the Jun 15, 2023 notice
−198 -$1.8K EDGAR
2023-06-13 OLMA Notice (144)
Officer · Planned Jun 13, 2023
Sold: listed on the Jun 14, 2023 notice
−9,213 -$86.2K EDGAR
2023-06-12 OLMA Notice (144)
Other · Planned Jun 12, 2023
Sold: listed on the Jun 13, 2023 notice
−41,167 -$365.0K EDGAR
2023-06-09 OLMA Notice (144)
Officer · Planned Jun 9, 2023
Sold: listed on the Jun 12, 2023 notice
−65,000 -$488.2K EDGAR
2023-06-08 OLMA Notice (144)
Officer · Planned Jun 8, 2023
Sold: listed on the Jun 9, 2023 notice
−15,000 -$93.0K EDGAR
Showing 11–20 of 58
Page 2 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).

Sales Reported Only on Form 144

13 sales · $1.65M
Each Form 144 lists the seller's sales of the company's stock in the 3 months before it. These are the sales on this filer's notices that no Form 4 on file shows, which is the usual case once someone is no longer an officer or director, or for an affiliate who never files Form 4s. Each sale is listed once, with the first notice that reported it.
Sold Symbol Shares Proceeds Avg Price Listed On
2023-07-18 OLMA 15,000 $133.8K $8.92 2023-07-20
2023-06-29 OLMA 7,500 $71.2K $9.50 2023-07-18
2023-06-28 OLMA 12,851 $123.1K $9.58 2023-06-29
2023-06-27 OLMA 15,029 $133.3K $8.87 2023-06-28
2023-06-15 OLMA 31 $287 $9.26 2023-06-27
2023-06-14 OLMA 198 $1.8K $9.29 2023-06-15
2023-06-13 OLMA 9,213 $86.2K $9.35 2023-06-14
2023-06-12 OLMA 41,167 $365.0K $8.87 2023-06-13
2023-06-09 OLMA 65,000 $488.2K $7.51 2023-06-12
2023-06-08 OLMA 15,000 $93.0K $6.20 2023-06-09
2023-06-06 OLMA 10,000 $62.8K $6.28 2023-06-08
2023-06-05 OLMA 10,023 $60.4K $6.03 2023-06-06
2023-05-19 OLMA 5,000 $35.8K $7.17 2023-06-05